As this gene interacts with ubiquitin conjugating enzyme E2 variant 1 (encoded by UBE2V1, which was detected as a gene associated with OS, Table 2), this UBE2V1 seems to be a novel molecular biomarker able to predict poor prognosis in breast cancer. This evidence concerns the gene UBE2V1 and breast carcinoma.